Long-term survival of high-risk melanoma patients immunized with a Hyper-IL-6-modified allogeneic whole-cell vaccine after complete resection

2012 ◽  
Vol 21 (6) ◽  
pp. 773-783 ◽  
Author(s):  
Andrzej Mackiewicz ◽  
Jacek Mackiewicz ◽  
Piotr J. Wysocki ◽  
Maciej Wiznerowicz ◽  
Malgorzata Kapcinska ◽  
...  
Keyword(s):  
High Risk ◽  
Complete Resection ◽  
Cell Vaccine ◽  
Term Survival ◽  
Whole Cell ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Whole Cell Vaccine ◽  
Melanoma Patients

Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients

2003 ◽  
Vol 119 (1-2) ◽  
pp. 125-132 ◽  
Author(s):  
Arthur R. Van Gool ◽  
Durk Fekkes ◽  
Wim H.J. Kruit ◽  
Paul G.H. Mulder ◽  
Timo L.M. Ten Hagen ◽  
...  
Keyword(s):  
Amino Acids ◽  
High Risk ◽  
Interferon Alpha ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Serum Amino Acids ◽  
Melanoma Patients

scholarly journals Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV)

2002 ◽  
Vol 86 (10) ◽  
pp. 1534-1539 ◽  
Author(s):  
M Lotem ◽  
T Peretz ◽  
O Drize ◽  
Z Gimmon ◽  
D Ad El ◽  
...  
Keyword(s):  
High Risk ◽  
Adjuvant Treatment ◽  
Cell Vaccine ◽  
Autologous Cell ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Melanoma Patients

scholarly journals CN4 COST-EFFECTIVENESS (CE) ANALYSIS OF INTERFERON-ALPHA IN HIGH-RISK MELANOMA PATIENTS

2004 ◽  
Vol 7 (3) ◽  
pp. 221 ◽  
Author(s):  
M Ding ◽  
Y Xing ◽  
T Shih ◽  
D Cox ◽  
S Cantor ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
High Risk ◽  
Interferon Alpha ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Melanoma Patients

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients

2017 ◽  
Vol 67 (2) ◽  
pp. 285-298 ◽  
Author(s):  
Olivier Gasser ◽  
Katrina J. Sharples ◽  
Catherine Barrow ◽  
Geoffrey M. Williams ◽  
Evelyn Bauer ◽  
...  
Keyword(s):  
T Cells ◽  
Dendritic Cells ◽  
High Risk ◽  
Phase I ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Melanoma Patients ◽  
Polyfunctional T Cells

Neoadjuvant Systemic Therapy for High-Risk Melanoma Patients

2020 ◽  
pp. 767-793
Author(s):  
Emily Z. Keung ◽  
Rodabe N. Amaria ◽  
Vernon K. Sondak ◽  
Merrick I. Ross ◽  
John M. Kirkwood ◽  
...  
Keyword(s):  
High Risk ◽  
Systemic Therapy ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Neoadjuvant Systemic Therapy ◽  
Melanoma Patients

Lymphocyte Subpopulations and Interleukin Levels in High-Risk Melanoma Patients Treated With High-Dose Interferon A-2B

2002 ◽  
Vol 25 (6) ◽  
pp. 591-596 ◽  
Author(s):  
Helen Gogas ◽  
George Paterakis ◽  
Konstantina Frangia ◽  
Dimitrios Bafaloukos ◽  
Dimitrios Pectasides ◽  
...  
Keyword(s):  
High Risk ◽  
Lymphocyte Subpopulations ◽  
High Dose ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Melanoma Patients ◽  
High Dose Interferon
Sign in / Sign up

Export Citation Format

Share Document